Global Diagnostic Radiopharmaceuticals Market Research Report 2026(Status and Outlook)
Description
Report Overview
Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment in the body.Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
The global Diagnostic Radiopharmaceuticals market size was estimated at USD 5400.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Diagnostic Radiopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Diagnostic Radiopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Diagnostic Radiopharmaceuticals market.
Global Diagnostic Radiopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Technetium 99
Fluorine 18
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Diagnostic Radiopharmaceuticals Market
Overview of the regional outlook of the Diagnostic Radiopharmaceuticals Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Diagnostic Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Radiopharmaceuticals refer to a special class of drugs containing radionuclides for medical diagnosis and treatment. Compounds or biological agents labeled with radionuclides used for medical diagnosis or treatment in the body.Diagnostic radiopharmaceuticals are radioactive isotopes bound to biological molecules that can locate specific organs, tissues or cells in the human body. These radiopharmaceuticals can be used to diagnose diseases.In vivo radiopharmaceuticals can be divided into diagnostic radiopharmaceuticals and therapeutic radiopharmaceuticals, and the main diseases targeted include thyroid diseases, tumors, rheumatoid arthritis, bone metastasis, liver cancer, etc.The diagnostic radiopharmaceuticals market is primarily driven by the rising incidence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging techniques for accurate diagnosis. The increasing use of PET and SPECT scans in healthcare systems worldwide has significantly boosted demand for diagnostic radiopharmaceuticals. Furthermore, innovations in molecular imaging, along with a growing focus on early detection and personalized medicine, are expanding the role of diagnostic radiopharmaceuticals in improving patient outcomes.One of the key challenges facing the diagnostic radiopharmaceuticals market is the short half-life of many radiopharmaceutical compounds, which creates logistical difficulties in production, transportation, and storage. This limitation often requires proximity to specialized manufacturing facilities. Additionally, the market is constrained by regulatory barriers and the high costs associated with development and approval. Another challenge is the shortage of trained professionals in nuclear medicine, which limits the full utilization of diagnostic radiopharmaceuticals, particularly in emerging economies.North America is the world's major consumer region, with sales accounting for 40% of the global total in 2023. Europe is also a major consumer region, accounting for 25% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
The global Diagnostic Radiopharmaceuticals market size was estimated at USD 5400.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.90% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Diagnostic Radiopharmaceuticals market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Diagnostic Radiopharmaceuticals market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Diagnostic Radiopharmaceuticals market.
Global Diagnostic Radiopharmaceuticals Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Cardinal Health
GE Healthcare
Jubilant Pharma
Novartis
Curium Pharma
SIEMENS
Lantheus
Bracco Imaging
Eli Lilly
China Isotope & Radiation
Dongcheng
Market Segmentation (by Type)
Technetium 99
Fluorine 18
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Diagnostic Radiopharmaceuticals Market
Overview of the regional outlook of the Diagnostic Radiopharmaceuticals Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Diagnostic Radiopharmaceuticals Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Diagnostic Radiopharmaceuticals, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
146 Pages
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Diagnostic Radiopharmaceuticals
- 1.2 Key Market Segments
- 1.2.1 Diagnostic Radiopharmaceuticals Segment by Type
- 1.2.2 Diagnostic Radiopharmaceuticals Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Diagnostic Radiopharmaceuticals Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Diagnostic Radiopharmaceuticals Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 3 Diagnostic Radiopharmaceuticals Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Diagnostic Radiopharmaceuticals Product Life Cycle
- 3.3 Global Diagnostic Radiopharmaceuticals Sales by Manufacturers (2020-2025)
- 3.4 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
- 3.8 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
- 3.8.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Diagnostic Radiopharmaceuticals Industry Chain Analysis
- 4.1 Diagnostic Radiopharmaceuticals Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Diagnostic Radiopharmaceuticals Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Diagnostic Radiopharmaceuticals Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Diagnostic Radiopharmaceuticals Market
- 5.7 ESG Ratings of Leading Companies
- 6 Diagnostic Radiopharmaceuticals Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2020-2025)
- 6.3 Global Diagnostic Radiopharmaceuticals Market Size by Type (2020-2025)
- 6.4 Global Diagnostic Radiopharmaceuticals Price by Type (2020-2025)
- 7 Diagnostic Radiopharmaceuticals Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Diagnostic Radiopharmaceuticals Market Sales by Application (2020-2025)
- 7.3 Global Diagnostic Radiopharmaceuticals Market Size (M USD) by Application (2020-2025)
- 7.4 Global Diagnostic Radiopharmaceuticals Sales Growth Rate by Application (2020-2025)
- 8 Diagnostic Radiopharmaceuticals Market Sales by Region
- 8.1 Global Diagnostic Radiopharmaceuticals Sales by Region
- 8.1.1 Global Diagnostic Radiopharmaceuticals Sales by Region
- 8.1.2 Global Diagnostic Radiopharmaceuticals Sales Market Share by Region
- 8.2 Global Diagnostic Radiopharmaceuticals Market Size by Region
- 8.2.1 Global Diagnostic Radiopharmaceuticals Market Size by Region
- 8.2.2 Global Diagnostic Radiopharmaceuticals Market Size by Region
- 8.3 North America
- 8.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country
- 8.3.2 North America Diagnostic Radiopharmaceuticals Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
- 8.4.2 Europe Diagnostic Radiopharmaceuticals Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
- 8.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Diagnostic Radiopharmaceuticals Sales by Country
- 8.6.2 South America Diagnostic Radiopharmaceuticals Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Region
- 8.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Diagnostic Radiopharmaceuticals Market Production by Region
- 9.1 Global Production of Diagnostic Radiopharmaceuticals by Region(2020-2025)
- 9.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Region (2020-2025)
- 9.3 Global Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Diagnostic Radiopharmaceuticals Production
- 9.4.1 North America Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.4.2 North America Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Diagnostic Radiopharmaceuticals Production
- 9.5.1 Europe Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.5.2 Europe Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Diagnostic Radiopharmaceuticals Production (2020-2025)
- 9.6.1 Japan Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.6.2 Japan Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Diagnostic Radiopharmaceuticals Production (2020-2025)
- 9.7.1 China Diagnostic Radiopharmaceuticals Production Growth Rate (2020-2025)
- 9.7.2 China Diagnostic Radiopharmaceuticals Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Cardinal Health
- 10.1.1 Cardinal Health Basic Information
- 10.1.2 Cardinal Health Diagnostic Radiopharmaceuticals Product Overview
- 10.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Product Market Performance
- 10.1.4 Cardinal Health Business Overview
- 10.1.5 Cardinal Health SWOT Analysis
- 10.1.6 Cardinal Health Recent Developments
- 10.2 GE Healthcare
- 10.2.1 GE Healthcare Basic Information
- 10.2.2 GE Healthcare Diagnostic Radiopharmaceuticals Product Overview
- 10.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Product Market Performance
- 10.2.4 GE Healthcare Business Overview
- 10.2.5 GE Healthcare SWOT Analysis
- 10.2.6 GE Healthcare Recent Developments
- 10.3 Jubilant Pharma
- 10.3.1 Jubilant Pharma Basic Information
- 10.3.2 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Overview
- 10.3.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Market Performance
- 10.3.4 Jubilant Pharma Business Overview
- 10.3.5 Jubilant Pharma SWOT Analysis
- 10.3.6 Jubilant Pharma Recent Developments
- 10.4 Novartis
- 10.4.1 Novartis Basic Information
- 10.4.2 Novartis Diagnostic Radiopharmaceuticals Product Overview
- 10.4.3 Novartis Diagnostic Radiopharmaceuticals Product Market Performance
- 10.4.4 Novartis Business Overview
- 10.4.5 Novartis Recent Developments
- 10.5 Curium Pharma
- 10.5.1 Curium Pharma Basic Information
- 10.5.2 Curium Pharma Diagnostic Radiopharmaceuticals Product Overview
- 10.5.3 Curium Pharma Diagnostic Radiopharmaceuticals Product Market Performance
- 10.5.4 Curium Pharma Business Overview
- 10.5.5 Curium Pharma Recent Developments
- 10.6 SIEMENS
- 10.6.1 SIEMENS Basic Information
- 10.6.2 SIEMENS Diagnostic Radiopharmaceuticals Product Overview
- 10.6.3 SIEMENS Diagnostic Radiopharmaceuticals Product Market Performance
- 10.6.4 SIEMENS Business Overview
- 10.6.5 SIEMENS Recent Developments
- 10.7 Lantheus
- 10.7.1 Lantheus Basic Information
- 10.7.2 Lantheus Diagnostic Radiopharmaceuticals Product Overview
- 10.7.3 Lantheus Diagnostic Radiopharmaceuticals Product Market Performance
- 10.7.4 Lantheus Business Overview
- 10.7.5 Lantheus Recent Developments
- 10.8 Bracco Imaging
- 10.8.1 Bracco Imaging Basic Information
- 10.8.2 Bracco Imaging Diagnostic Radiopharmaceuticals Product Overview
- 10.8.3 Bracco Imaging Diagnostic Radiopharmaceuticals Product Market Performance
- 10.8.4 Bracco Imaging Business Overview
- 10.8.5 Bracco Imaging Recent Developments
- 10.9 Eli Lilly
- 10.9.1 Eli Lilly Basic Information
- 10.9.2 Eli Lilly Diagnostic Radiopharmaceuticals Product Overview
- 10.9.3 Eli Lilly Diagnostic Radiopharmaceuticals Product Market Performance
- 10.9.4 Eli Lilly Business Overview
- 10.9.5 Eli Lilly Recent Developments
- 10.10 China Isotope and Radiation
- 10.10.1 China Isotope and Radiation Basic Information
- 10.10.2 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Overview
- 10.10.3 China Isotope and Radiation Diagnostic Radiopharmaceuticals Product Market Performance
- 10.10.4 China Isotope and Radiation Business Overview
- 10.10.5 China Isotope and Radiation Recent Developments
- 10.11 Dongcheng
- 10.11.1 Dongcheng Basic Information
- 10.11.2 Dongcheng Diagnostic Radiopharmaceuticals Product Overview
- 10.11.3 Dongcheng Diagnostic Radiopharmaceuticals Product Market Performance
- 10.11.4 Dongcheng Business Overview
- 10.11.5 Dongcheng Recent Developments
- 11 Diagnostic Radiopharmaceuticals Market Forecast by Region
- 11.1 Global Diagnostic Radiopharmaceuticals Market Size Forecast
- 11.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Diagnostic Radiopharmaceuticals Market Size Forecast by Country
- 11.2.3 Asia Pacific Diagnostic Radiopharmaceuticals Market Size Forecast by Region
- 11.2.4 South America Diagnostic Radiopharmaceuticals Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Diagnostic Radiopharmaceuticals by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Diagnostic Radiopharmaceuticals Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2026-2035)
- 12.1.2 Global Diagnostic Radiopharmaceuticals Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Diagnostic Radiopharmaceuticals by Type (2026-2035)
- 12.2 Global Diagnostic Radiopharmaceuticals Market Forecast by Application (2026-2035)
- 12.2.1 Global Diagnostic Radiopharmaceuticals Sales (K MT) Forecast by Application
- 12.2.2 Global Diagnostic Radiopharmaceuticals Market Size (M USD) Forecast by Application (2026-2035)
- 13 Conclusion and Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
